nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—PDE4C—DARPP-32 events—PPP3R1—peripheral nervous system neoplasm	0.0138	0.0869	CbGpPWpGaD
Roflumilast—PDE4D—DARPP-32 events—PPP3R1—peripheral nervous system neoplasm	0.012	0.0757	CbGpPWpGaD
Roflumilast—PDE4A—DARPP-32 events—PPP3R1—peripheral nervous system neoplasm	0.0115	0.072	CbGpPWpGaD
Roflumilast—PDE4B—DARPP-32 events—PPP3R1—peripheral nervous system neoplasm	0.0106	0.0667	CbGpPWpGaD
Roflumilast—PDE4C—Opioid Signalling—PPP3R1—peripheral nervous system neoplasm	0.00558	0.035	CbGpPWpGaD
Roflumilast—PDE4C—ganglion—peripheral nervous system neoplasm	0.00552	0.301	CbGeAlD
Roflumilast—PDE4C—tongue—peripheral nervous system neoplasm	0.00546	0.298	CbGeAlD
Roflumilast—PDE4D—Opioid Signalling—PPP3R1—peripheral nervous system neoplasm	0.00485	0.0305	CbGpPWpGaD
Roflumilast—PDE4A—Opioid Signalling—PPP3R1—peripheral nervous system neoplasm	0.00462	0.029	CbGpPWpGaD
Roflumilast—PDE4C—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.0043	0.027	CbGpPWpGaD
Roflumilast—PDE4B—Opioid Signalling—PPP3R1—peripheral nervous system neoplasm	0.00428	0.0269	CbGpPWpGaD
Roflumilast—PDE4D—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.00374	0.0235	CbGpPWpGaD
Roflumilast—PDE4A—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.00356	0.0224	CbGpPWpGaD
Roflumilast—PDE4B—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.0033	0.0207	CbGpPWpGaD
Roflumilast—PDE4D—TSH signaling pathway—GNAS—peripheral nervous system neoplasm	0.00321	0.0202	CbGpPWpGaD
Roflumilast—PDE4C—G Protein Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.0028	0.0176	CbGpPWpGaD
Roflumilast—PDE4D—G Protein Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00244	0.0153	CbGpPWpGaD
Roflumilast—PDE4C—brainstem—peripheral nervous system neoplasm	0.0024	0.131	CbGeAlD
Roflumilast—PDE4A—G Protein Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00232	0.0146	CbGpPWpGaD
Roflumilast—PDE4C—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00223	0.014	CbGpPWpGaD
Roflumilast—PDE4B—G Protein Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00215	0.0135	CbGpPWpGaD
Roflumilast—PDE4D—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00194	0.0122	CbGpPWpGaD
Roflumilast—PDE4A—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00185	0.0116	CbGpPWpGaD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00172	0.0021	CcSEcCtD
Roflumilast—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00172	0.00209	CcSEcCtD
Roflumilast—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00172	0.00209	CcSEcCtD
Roflumilast—PDE4B—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00171	0.0107	CbGpPWpGaD
Roflumilast—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.0017	0.00206	CcSEcCtD
Roflumilast—Myalgia—Vincristine—peripheral nervous system neoplasm	0.00167	0.00203	CcSEcCtD
Roflumilast—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00167	0.00203	CcSEcCtD
Roflumilast—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00165	0.00201	CcSEcCtD
Roflumilast—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00165	0.00201	CcSEcCtD
Roflumilast—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.00165	0.002	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00164	0.00199	CcSEcCtD
Roflumilast—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00163	0.00198	CcSEcCtD
Roflumilast—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00163	0.00198	CcSEcCtD
Roflumilast—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00163	0.00198	CcSEcCtD
Roflumilast—PDE4D—Myometrial Relaxation and Contraction Pathways—GNAS—peripheral nervous system neoplasm	0.00162	0.0102	CbGpPWpGaD
Roflumilast—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00162	0.00197	CcSEcCtD
Roflumilast—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00162	0.00197	CcSEcCtD
Roflumilast—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00162	0.00197	CcSEcCtD
Roflumilast—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00161	0.00196	CcSEcCtD
Roflumilast—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.0016	0.00195	CcSEcCtD
Roflumilast—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.0016	0.00194	CcSEcCtD
Roflumilast—Infection—Vincristine—peripheral nervous system neoplasm	0.00159	0.00194	CcSEcCtD
Roflumilast—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00159	0.00193	CcSEcCtD
Roflumilast—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00158	0.00192	CcSEcCtD
Roflumilast—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00158	0.00192	CcSEcCtD
Roflumilast—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00157	0.00191	CcSEcCtD
Roflumilast—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00157	0.00191	CcSEcCtD
Roflumilast—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00156	0.0019	CcSEcCtD
Roflumilast—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00156	0.0019	CcSEcCtD
Roflumilast—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00156	0.00189	CcSEcCtD
Roflumilast—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00155	0.00188	CcSEcCtD
Roflumilast—Back pain—Etoposide—peripheral nervous system neoplasm	0.00154	0.00187	CcSEcCtD
Roflumilast—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00153	0.00186	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00152	0.00184	CcSEcCtD
Roflumilast—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00151	0.00184	CcSEcCtD
Roflumilast—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00151	0.00183	CcSEcCtD
Roflumilast—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.0015	0.00183	CcSEcCtD
Roflumilast—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.0015	0.00183	CcSEcCtD
Roflumilast—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.00148	0.00181	CcSEcCtD
Roflumilast—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00148	0.0018	CcSEcCtD
Roflumilast—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00148	0.0018	CcSEcCtD
Roflumilast—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00148	0.0018	CcSEcCtD
Roflumilast—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00148	0.0018	CcSEcCtD
Roflumilast—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00147	0.00179	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00147	0.00179	CcSEcCtD
Roflumilast—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00147	0.00178	CcSEcCtD
Roflumilast—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00147	0.00178	CcSEcCtD
Roflumilast—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00146	0.00178	CcSEcCtD
Roflumilast—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00146	0.00178	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00146	0.00178	CcSEcCtD
Roflumilast—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00145	0.00177	CcSEcCtD
Roflumilast—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00145	0.00177	CcSEcCtD
Roflumilast—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00145	0.00176	CcSEcCtD
Roflumilast—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00145	0.00176	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00144	0.00175	CcSEcCtD
Roflumilast—Malaise—Etoposide—peripheral nervous system neoplasm	0.00144	0.00175	CcSEcCtD
Roflumilast—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00143	0.00174	CcSEcCtD
Roflumilast—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00143	0.00174	CcSEcCtD
Roflumilast—PDE4B—Myometrial Relaxation and Contraction Pathways—GNAS—peripheral nervous system neoplasm	0.00143	0.00898	CbGpPWpGaD
Roflumilast—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00142	0.00173	CcSEcCtD
Roflumilast—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00142	0.00173	CcSEcCtD
Roflumilast—Infection—Cisplatin—peripheral nervous system neoplasm	0.00141	0.00171	CcSEcCtD
Roflumilast—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00141	0.00171	CcSEcCtD
Roflumilast—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.0014	0.0017	CcSEcCtD
Roflumilast—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.0014	0.0017	CcSEcCtD
Roflumilast—Rash—Topotecan—peripheral nervous system neoplasm	0.0014	0.0017	CcSEcCtD
Roflumilast—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00139	0.0017	CcSEcCtD
Roflumilast—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00139	0.0017	CcSEcCtD
Roflumilast—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00139	0.00169	CcSEcCtD
Roflumilast—Headache—Topotecan—peripheral nervous system neoplasm	0.00139	0.00169	CcSEcCtD
Roflumilast—Rash—Tretinoin—peripheral nervous system neoplasm	0.00138	0.00168	CcSEcCtD
Roflumilast—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00138	0.00168	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00138	0.00168	CcSEcCtD
Roflumilast—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00138	0.00168	CcSEcCtD
Roflumilast—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00138	0.00168	CcSEcCtD
Roflumilast—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00138	0.00168	CcSEcCtD
Roflumilast—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00138	0.00168	CcSEcCtD
Roflumilast—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00138	0.00167	CcSEcCtD
Roflumilast—Headache—Tretinoin—peripheral nervous system neoplasm	0.00138	0.00167	CcSEcCtD
Roflumilast—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00138	0.00167	CcSEcCtD
Roflumilast—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00137	0.00167	CcSEcCtD
Roflumilast—Constipation—Vincristine—peripheral nervous system neoplasm	0.00137	0.00167	CcSEcCtD
Roflumilast—Rash—Melphalan—peripheral nervous system neoplasm	0.00137	0.00166	CcSEcCtD
Roflumilast—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00137	0.00166	CcSEcCtD
Roflumilast—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.00165	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00135	0.00164	CcSEcCtD
Roflumilast—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00134	0.00163	CcSEcCtD
Roflumilast—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00132	0.00161	CcSEcCtD
Roflumilast—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00161	CcSEcCtD
Roflumilast—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.0016	CcSEcCtD
Roflumilast—Nausea—Topotecan—peripheral nervous system neoplasm	0.00131	0.0016	CcSEcCtD
Roflumilast—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00131	0.00159	CcSEcCtD
Roflumilast—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.00131	0.00159	CcSEcCtD
Roflumilast—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.0013	0.00159	CcSEcCtD
Roflumilast—Nausea—Tretinoin—peripheral nervous system neoplasm	0.0013	0.00159	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00129	0.00157	CcSEcCtD
Roflumilast—Infection—Etoposide—peripheral nervous system neoplasm	0.00129	0.00157	CcSEcCtD
Roflumilast—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00129	0.00157	CcSEcCtD
Roflumilast—Nausea—Melphalan—peripheral nervous system neoplasm	0.00129	0.00157	CcSEcCtD
Roflumilast—Influenza—Epirubicin—peripheral nervous system neoplasm	0.00128	0.00156	CcSEcCtD
Roflumilast—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00127	0.00154	CcSEcCtD
Roflumilast—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00126	0.00153	CcSEcCtD
Roflumilast—PDE4B—trigeminal ganglion—peripheral nervous system neoplasm	0.00126	0.0687	CbGeAlD
Roflumilast—PDE4D—TSH signaling pathway—MYC—peripheral nervous system neoplasm	0.00125	0.00786	CbGpPWpGaD
Roflumilast—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00123	0.0015	CcSEcCtD
Roflumilast—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00123	0.00149	CcSEcCtD
Roflumilast—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00123	0.00149	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00149	CcSEcCtD
Roflumilast—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.00148	CcSEcCtD
Roflumilast—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00145	CcSEcCtD
Roflumilast—PDE4B—parotid gland—peripheral nervous system neoplasm	0.00119	0.0648	CbGeAlD
Roflumilast—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.00118	0.00144	CcSEcCtD
Roflumilast—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00118	0.00144	CcSEcCtD
Roflumilast—PDE4C—G Protein Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.00117	0.00736	CbGpPWpGaD
Roflumilast—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00117	0.00142	CcSEcCtD
Roflumilast—PDE4C—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00116	0.00731	CbGpPWpGaD
Roflumilast—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00141	CcSEcCtD
Roflumilast—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00115	0.0014	CcSEcCtD
Roflumilast—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00115	0.0014	CcSEcCtD
Roflumilast—Infestation—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00139	CcSEcCtD
Roflumilast—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00139	CcSEcCtD
Roflumilast—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00114	0.00139	CcSEcCtD
Roflumilast—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00138	CcSEcCtD
Roflumilast—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00113	0.00138	CcSEcCtD
Roflumilast—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00113	0.00137	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00112	0.00136	CcSEcCtD
Roflumilast—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00112	0.00136	CcSEcCtD
Roflumilast—Constipation—Etoposide—peripheral nervous system neoplasm	0.00111	0.00135	CcSEcCtD
Roflumilast—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00135	CcSEcCtD
Roflumilast—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00134	CcSEcCtD
Roflumilast—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.0011	0.00133	CcSEcCtD
Roflumilast—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00131	CcSEcCtD
Roflumilast—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.0013	CcSEcCtD
Roflumilast—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.00107	0.0013	CcSEcCtD
Roflumilast—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00107	0.0013	CcSEcCtD
Roflumilast—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.0013	CcSEcCtD
Roflumilast—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00129	CcSEcCtD
Roflumilast—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00106	0.00129	CcSEcCtD
Roflumilast—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00106	0.00129	CcSEcCtD
Roflumilast—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00106	0.00129	CcSEcCtD
Roflumilast—PDE4C—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00106	0.00664	CbGpPWpGaD
Roflumilast—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00128	CcSEcCtD
Roflumilast—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00128	CcSEcCtD
Roflumilast—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.00128	CcSEcCtD
Roflumilast—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.00127	CcSEcCtD
Roflumilast—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00127	CcSEcCtD
Roflumilast—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00104	0.00127	CcSEcCtD
Roflumilast—PDE4D—cerebellum—peripheral nervous system neoplasm	0.00104	0.0568	CbGeAlD
Roflumilast—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00103	0.00125	CcSEcCtD
Roflumilast—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00125	CcSEcCtD
Roflumilast—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00103	0.00125	CcSEcCtD
Roflumilast—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00125	CcSEcCtD
Roflumilast—PDE4D—G Protein Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.00102	0.00641	CbGpPWpGaD
Roflumilast—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00102	0.00124	CcSEcCtD
Roflumilast—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00124	CcSEcCtD
Roflumilast—PDE4C—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00101	0.00636	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00101	0.00636	CbGpPWpGaD
Roflumilast—Rash—Vincristine—peripheral nervous system neoplasm	0.00101	0.00123	CcSEcCtD
Roflumilast—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00101	0.00123	CcSEcCtD
Roflumilast—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00122	CcSEcCtD
Roflumilast—Headache—Vincristine—peripheral nervous system neoplasm	0.001	0.00122	CcSEcCtD
Roflumilast—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000999	0.00121	CcSEcCtD
Roflumilast—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000991	0.00121	CcSEcCtD
Roflumilast—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000989	0.0012	CcSEcCtD
Roflumilast—PDE4D—TSH signaling pathway—HRAS—peripheral nervous system neoplasm	0.000982	0.00617	CbGpPWpGaD
Roflumilast—PDE4A—G Protein Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000971	0.0061	CbGpPWpGaD
Roflumilast—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00097	0.00118	CcSEcCtD
Roflumilast—PDE4A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000964	0.00606	CbGpPWpGaD
Roflumilast—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000957	0.00116	CcSEcCtD
Roflumilast—Nausea—Vincristine—peripheral nervous system neoplasm	0.000953	0.00116	CcSEcCtD
Roflumilast—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000951	0.00116	CcSEcCtD
Roflumilast—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000951	0.00116	CcSEcCtD
Roflumilast—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000932	0.00113	CcSEcCtD
Roflumilast—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000932	0.00113	CcSEcCtD
Roflumilast—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000926	0.00113	CcSEcCtD
Roflumilast—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000924	0.00112	CcSEcCtD
Roflumilast—PDE4A—cerebellum—peripheral nervous system neoplasm	0.000922	0.0503	CbGeAlD
Roflumilast—PDE4D—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00092	0.00578	CbGpPWpGaD
Roflumilast—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000902	0.0011	CcSEcCtD
Roflumilast—PDE4B—G Protein Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000899	0.00564	CbGpPWpGaD
Roflumilast—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000898	0.00109	CcSEcCtD
Roflumilast—Rash—Cisplatin—peripheral nervous system neoplasm	0.000894	0.00109	CcSEcCtD
Roflumilast—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000893	0.00109	CcSEcCtD
Roflumilast—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000892	0.00108	CcSEcCtD
Roflumilast—PDE4B—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000892	0.0056	CbGpPWpGaD
Roflumilast—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000889	0.00108	CcSEcCtD
Roflumilast—PDE4D—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000882	0.00554	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000882	0.00554	CbGpPWpGaD
Roflumilast—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00088	0.00107	CcSEcCtD
Roflumilast—Tension—Epirubicin—peripheral nervous system neoplasm	0.000876	0.00106	CcSEcCtD
Roflumilast—PDE4A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000875	0.0055	CbGpPWpGaD
Roflumilast—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000874	0.00106	CcSEcCtD
Roflumilast—PDE4D—TSH signaling pathway—AKT1—peripheral nervous system neoplasm	0.000867	0.00545	CbGpPWpGaD
Roflumilast—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000867	0.00105	CcSEcCtD
Roflumilast—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000863	0.00105	CcSEcCtD
Roflumilast—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000859	0.00104	CcSEcCtD
Roflumilast—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000858	0.00104	CcSEcCtD
Roflumilast—PDE4C—G Protein Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000857	0.00539	CbGpPWpGaD
Roflumilast—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000857	0.00104	CcSEcCtD
Roflumilast—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000855	0.00104	CcSEcCtD
Roflumilast—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000842	0.00102	CcSEcCtD
Roflumilast—PDE4A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000839	0.00527	CbGpPWpGaD
Roflumilast—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000831	0.00101	CcSEcCtD
Roflumilast—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000828	0.00101	CcSEcCtD
Roflumilast—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000826	0.001	CcSEcCtD
Roflumilast—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000826	0.001	CcSEcCtD
Roflumilast—Rash—Etoposide—peripheral nervous system neoplasm	0.000819	0.000996	CcSEcCtD
Roflumilast—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000818	0.000995	CcSEcCtD
Roflumilast—Headache—Etoposide—peripheral nervous system neoplasm	0.000814	0.00099	CcSEcCtD
Roflumilast—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00081	0.000985	CcSEcCtD
Roflumilast—PDE4B—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00081	0.00509	CbGpPWpGaD
Roflumilast—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000808	0.000983	CcSEcCtD
Roflumilast—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000805	0.000978	CcSEcCtD
Roflumilast—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000802	0.000975	CcSEcCtD
Roflumilast—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000802	0.000975	CcSEcCtD
Roflumilast—PDE4C—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000801	0.00503	CbGpPWpGaD
Roflumilast—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000799	0.000971	CcSEcCtD
Roflumilast—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000794	0.000965	CcSEcCtD
Roflumilast—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000789	0.000959	CcSEcCtD
Roflumilast—PDE4B—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000777	0.00488	CbGpPWpGaD
Roflumilast—Nausea—Etoposide—peripheral nervous system neoplasm	0.000772	0.000938	CcSEcCtD
Roflumilast—PDE4D—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000768	0.00482	CbGpPWpGaD
Roflumilast—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000766	0.000931	CcSEcCtD
Roflumilast—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.00076	0.000924	CcSEcCtD
Roflumilast—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000757	0.00092	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000754	0.000917	CcSEcCtD
Roflumilast—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000751	0.000913	CcSEcCtD
Roflumilast—PDE4D—G Protein Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000746	0.00469	CbGpPWpGaD
Roflumilast—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000745	0.000905	CcSEcCtD
Roflumilast—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000742	0.000902	CcSEcCtD
Roflumilast—PDE4C—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000739	0.00464	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000731	0.00459	CbGpPWpGaD
Roflumilast—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00073	0.000887	CcSEcCtD
Roflumilast—Infection—Epirubicin—peripheral nervous system neoplasm	0.000723	0.00088	CcSEcCtD
Roflumilast—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000714	0.000868	CcSEcCtD
Roflumilast—PDE4A—G Protein Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.00071	0.00446	CbGpPWpGaD
Roflumilast—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000707	0.00086	CcSEcCtD
Roflumilast—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000703	0.000855	CcSEcCtD
Roflumilast—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.0007	0.000852	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000698	0.000849	CcSEcCtD
Roflumilast—PDE4D—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000697	0.00438	CbGpPWpGaD
Roflumilast—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000694	0.000844	CcSEcCtD
Roflumilast—PDE4B—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000676	0.00425	CbGpPWpGaD
Roflumilast—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000669	0.000814	CcSEcCtD
Roflumilast—PDE4A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000663	0.00417	CbGpPWpGaD
Roflumilast—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000663	0.000807	CcSEcCtD
Roflumilast—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000661	0.000803	CcSEcCtD
Roflumilast—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000659	0.000801	CcSEcCtD
Roflumilast—PDE4B—G Protein Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000657	0.00413	CbGpPWpGaD
Roflumilast—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000654	0.000796	CcSEcCtD
Roflumilast—PDE4D—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000643	0.00404	CbGpPWpGaD
Roflumilast—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000641	0.000779	CcSEcCtD
Roflumilast—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000633	0.00077	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000629	0.000764	CcSEcCtD
Roflumilast—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000628	0.000763	CcSEcCtD
Roflumilast—PDE4C—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000624	0.00392	CbGpPWpGaD
Roflumilast—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000623	0.000757	CcSEcCtD
Roflumilast—PDE4B—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000614	0.00386	CbGpPWpGaD
Roflumilast—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000614	0.000746	CcSEcCtD
Roflumilast—PDE4A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000612	0.00385	CbGpPWpGaD
Roflumilast—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000609	0.000741	CcSEcCtD
Roflumilast—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.0006	0.00073	CcSEcCtD
Roflumilast—PDE4C—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000598	0.00376	CbGpPWpGaD
Roflumilast—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000595	0.000724	CcSEcCtD
Roflumilast—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000593	0.000721	CcSEcCtD
Roflumilast—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000586	0.000712	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.000707	CcSEcCtD
Roflumilast—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000581	0.000706	CcSEcCtD
Roflumilast—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000579	0.000703	CcSEcCtD
Roflumilast—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000576	0.000701	CcSEcCtD
Roflumilast—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000576	0.0007	CcSEcCtD
Roflumilast—PDE4B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000567	0.00356	CbGpPWpGaD
Roflumilast—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000555	0.000675	CcSEcCtD
Roflumilast—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000551	0.00067	CcSEcCtD
Roflumilast—PDE4B—cerebellum—peripheral nervous system neoplasm	0.00055	0.03	CbGeAlD
Roflumilast—PDE4D—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000543	0.00341	CbGpPWpGaD
Roflumilast—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000537	0.000652	CcSEcCtD
Roflumilast—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000535	0.000651	CcSEcCtD
Roflumilast—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000533	0.000648	CcSEcCtD
Roflumilast—PDE4C—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000523	0.00328	CbGpPWpGaD
Roflumilast—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000522	0.000635	CcSEcCtD
Roflumilast—PDE4D—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000521	0.00327	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000517	0.00325	CbGpPWpGaD
Roflumilast—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000498	0.000606	CcSEcCtD
Roflumilast—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000496	0.000604	CcSEcCtD
Roflumilast—PDE4A—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000496	0.00311	CbGpPWpGaD
Roflumilast—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000483	0.000588	CcSEcCtD
Roflumilast—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000482	0.000586	CcSEcCtD
Roflumilast—PDE4B—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000479	0.00301	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000475	0.00298	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000473	0.00297	CbGpPWpGaD
Roflumilast—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000463	0.000563	CcSEcCtD
Roflumilast—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.000561	CcSEcCtD
Roflumilast—Rash—Epirubicin—peripheral nervous system neoplasm	0.000459	0.000558	CcSEcCtD
Roflumilast—PDE4B—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000459	0.00288	CbGpPWpGaD
Roflumilast—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000459	0.000558	CcSEcCtD
Roflumilast—PDE4C—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000457	0.00287	CbGpPWpGaD
Roflumilast—Headache—Epirubicin—peripheral nervous system neoplasm	0.000456	0.000555	CcSEcCtD
Roflumilast—PDE4D—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000455	0.00286	CbGpPWpGaD
Roflumilast—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000446	0.000542	CcSEcCtD
Roflumilast—PDE4C—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000437	0.00274	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000433	0.00272	CbGpPWpGaD
Roflumilast—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000526	CcSEcCtD
Roflumilast—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.000521	CcSEcCtD
Roflumilast—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000425	0.000517	CcSEcCtD
Roflumilast—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000424	0.000516	CcSEcCtD
Roflumilast—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000422	0.000513	CcSEcCtD
Roflumilast—PDE4C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000415	0.00261	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000413	0.0026	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000412	0.00259	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000401	0.00252	CbGpPWpGaD
Roflumilast—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.000487	CcSEcCtD
Roflumilast—PDE4D—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000398	0.0025	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000393	0.00247	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000392	0.00246	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00038	0.00239	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000379	0.00238	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000364	0.00229	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000363	0.00228	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000362	0.00227	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000361	0.00227	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000351	0.0022	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000344	0.00216	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000335	0.0021	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000328	0.00206	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000318	0.002	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000289	0.00181	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000285	0.00179	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00028	0.00176	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000272	0.00171	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000267	0.00168	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000251	0.00158	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000251	0.00158	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000245	0.00154	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000244	0.00153	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000239	0.0015	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000233	0.00146	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000232	0.00146	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000221	0.00139	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000221	0.00139	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000215	0.00135	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000213	0.00134	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000205	0.00129	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000203	0.00128	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000188	0.00118	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000173	0.00109	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.00017	0.00107	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000151	0.000949	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000148	0.000932	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000144	0.000903	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000141	0.000887	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000135	0.000846	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000133	0.000836	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000131	0.000821	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000127	0.000797	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000123	0.000775	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000122	0.000768	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000117	0.000737	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000112	0.000704	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000112	0.000701	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.00011	0.000694	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000107	0.000675	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000106	0.000669	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000105	0.000661	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000103	0.000649	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000102	0.000644	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000102	0.000642	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000101	0.000636	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.75e-05	0.000613	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.73e-05	0.000611	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.55e-05	0.0006	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.46e-05	0.000594	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.37e-05	0.000589	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.29e-05	0.000583	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.92e-05	0.00056	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.59e-05	0.00054	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.49e-05	0.000533	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.31e-05	0.000522	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.91e-05	0.000497	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.86e-05	0.000494	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.84e-05	0.000492	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.5e-05	0.000471	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.32e-05	0.00046	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.82e-05	0.000429	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.62e-05	0.000416	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.53e-05	0.00041	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.5e-05	0.000408	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.21e-05	0.00039	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.01e-05	0.000378	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.76e-05	0.000362	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.75e-05	0.000361	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.48e-05	0.000345	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.08e-05	0.000319	CbGpPWpGaD
